tirzepatide
Showing 26 - 49 of 49
Type 2 Diabetes, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Not yet recruiting
- Type 2 Diabetes
- Obesity
- Tirzepatide
- Placebo
-
Caba, Buenos Aires, Argentina
- +48 more
Sep 8, 2023
Type 2 Diabetes Trial in Japan (Tirzepatide, Oral antihyperglycemic medication (OAM))
Completed
- Type 2 Diabetes Mellitus
- Tirzepatide
- Oral antihyperglycemic medication (OAM)
-
Chiba-shi, Chiba, Japan
- +33 more
Jan 21, 2022
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Glargine)
Completed
- Type 2 Diabetes
- Tirzepatide
- Insulin Glargine
-
Blacktown, New South Wales, Australia
- +66 more
Dec 12, 2022
Sleep Apnea, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Recruiting
- Sleep Apnea
- Obesity
- Tirzepatide
- Placebo
-
Riverside, California
- +66 more
Jan 23, 2023
Hepatic Insufficiency Trial in Tustin, Orlando, New Orleans (Tirzepatide)
Completed
- Hepatic Insufficiency
- Tirzepatide
-
Tustin, California
- +2 more
Oct 6, 2020
Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Obesity
- Overweight
- Tirzepatide
- Placebo
-
Huntington Park, California
- +64 more
Mar 22, 2022
Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Type 2 Diabetes
- +2 more
- Tirzepatide
- Placebo
-
Birmingham, Alabama
- +74 more
Apr 18, 2022
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Placebo)
Completed
- Type 2 Diabetes Mellitus
- Tirzepatide
- Placebo
-
Huntington Park, California
- +52 more
Oct 18, 2021
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Antihyperglycemic medication)
Not yet recruiting
- Type 2 Diabetes
- Tirzepatide
- Antihyperglycemic medication
-
Birmingham, Alabama
- +96 more
Aug 8, 2022
Nonalcoholic Steatohepatitis Trial in Worldwide (Tirzepatide, Placebo)
Recruiting
- Nonalcoholic Steatohepatitis
- Tirzepatide
- Placebo
-
Birmingham, Alabama
- +119 more
Aug 17, 2022
Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Obesity
- Overweight
- Tirzepatide
- Placebo
-
Pelham, Alabama
- +69 more
Oct 5, 2021
Obesity, Heart Failure With Preserved Ejection Fraction Trial in Worldwide (Tirzepatide, Placebo)
Recruiting
- Obesity
- Heart Failure With Preserved Ejection Fraction
- Tirzepatide
- Placebo
-
Huntsville, Alabama
- +144 more
Jan 18, 2023
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Lispro (U100), Insulin Glargine (U100))
Completed
- Type 2 Diabetes
- Tirzepatide
- +2 more
-
Sheffield, Alabama
- +134 more
Nov 22, 2022
Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Overweight
- Obesity
- Tirzepatide
- Placebo
-
Pelham, Alabama
- +119 more
Apr 12, 2022
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Semaglutide)
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Dulaglutide)
Active, not recruiting
- Type 2 Diabetes Mellitus
- Tirzepatide
- Dulaglutide
-
Birmingham, Alabama
- +646 more
Jan 18, 2023
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Degludec)
Completed
- Type 2 Diabetes Mellitus
- Tirzepatide
- Insulin Degludec
-
Little Rock, Arkansas
- +121 more
Jan 14, 2022
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Glargine)
Completed
- Type 2 Diabetes Mellitus
- Tirzepatide
- Insulin Glargine
-
Anaheim, California
- +215 more
Jan 21, 2022
Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)
Recruiting
- Obesity
- Overweight
- Tirzepatide
- Placebo
-
Gilbert, Arizona
- +695 more
Jan 18, 2023
Healthy Trial in Dallas (Tirzepatide, Placebo)
Completed
- Healthy
- Tirzepatide
- Placebo
-
Dallas, TexasCovance
Jan 31, 2019
Type 2 Diabetes Trial in Hachioji, Shinjuku-Ku (Tirzepatide, Placebo)
Completed
- Type 2 Diabetes Mellitus
- Tirzepatide
- Placebo
-
Hachioji, Tokyo, Japan
- +1 more
Jan 23, 2019
Type 2 Diabetes Trial in Worldwide (tirzepatide, Dulaglutide, Placebo)
Completed
- Type 2 Diabetes Mellitus
- tirzepatide
- +2 more
-
Mobile, Alabama
- +48 more
Jul 31, 2019